海量图书期刊资源,随时随地畅享阅读乐趣
Leukocyte-Specific CCL3 Deficiency Inhibits Atherosclerotic Lesion Development by Affecting Neutrophil Accumulationde Jager, S. C. A.; Bot, I.; Kraaijeveld, A. O.; Korporaal, S. J. A.; Bot, M.; van Santbrink, P. J.; van Berkel, T. J. C.; Kuiper, J.; Biessen, E. A. L. · Arteriosclerosis, Thrombosis, and Vascular Biology · 2013
Short Communication: The Neuropeptide Substance P Mediates Adventitial Mast Cell Activation and Induces Intraplaque Hemorrhage in Advanced AtherosclerosisBot, I.; de Jager, S. C.A.; Bot, M.; van Heiningen, S. H.; de Groot, P.; Veldhuizen, R. W.; van Berkel, T. J.C.; von der Thusen, J. H.; Biessen, E. A.L. · Circulation Research · 2010
Lysophosphatidic acid triggers mast cell-driven atherosclerotic plaque destabilization by increasing vascular inflammationBot, M.; de Jager, S. C. A.; MacAleese, L.; Lagraauw, H. M.; van Berkel, T. J. C.; Quax, P. H. A.; Kuiper, J.; Heeren, R. M. A.; Biessen, E. A. L.; Bot, I. · The Journal of Lipid Research · 2013
Mast cell chymase inhibition reduces atherosclerotic plaque progression and improves plaque stability in ApoE-/- miceBot, I.; Bot, M.; van Heiningen, S. H.; van Santbrink, P. J.; Lankhuizen, I. M.; Hartman, P.; Gruener, S.; Hilpert, H.; van Berkel, T. J. C.; Fingerle, J.; Biessen, E. A. L. · Cardiovascular Research · 2011
Myocardin Regulates Vascular Response to Injury Through miR-24/-29a and Platelet-Derived Growth Factor Receptor- Talasila, A.; Yu, H.; Ackers-Johnson, M.; Bot, M.; van Berkel, T.; Bennett, M. R.; Bot, I.; Sinha, S. · Arteriosclerosis, Thrombosis, and Vascular Biology · 2013
EpiplocelePellicé i Vilalta, C.; Pérez i Boté, F.; del Tura Bayona i Pujol, M.; Comas i Castell, S. · Actas Urológicas Españolas · 2003
Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxisde Jager, S. C. A.; Bermudez, B.; Bot, I.; Koenen, R. R.; Bot, M.; Kavelaars, A.; de Waard, V.; Heijnen, C. J.; Muriana, F. J. G.; Weber, C.; van Berkel, T. J. C.; Kuiper, J.; Lee, S.-J.; Abia, R.; Biessen, E. A. L. · Journal of Experimental Medicine · 2011
Selective Modulation of Nuclear Factor of Activated T-Cell Function in Restenosis by a Potent Bipartite Peptide InhibitorYu, H.; Bot, I.; Sliedregt, K.; Xu, X.; Bot, M.; van Heiningen, S. H.; van der Marel, G. A.; Bennett, M. R.; Overkleeft, H.; van Berkel, T. J. C.; Biessen, E. A. L. · Circulation Research · 2012
A Randomized, Double-blind, Placebo-Controlled, Phase III Trial of Pregabalin in the Treatment of Patients with FibromyalgiaMease, Philip J; Russell, I Jon; Arnold, Lesley M; Florian, Hana; Young, James P; Martin, Susan a; Sharma, Uma; Arnold, Fabré; Mease, P J; Russell, I J; Arnold, L M; Florian, H; Young, J P; Martin, S a · The Journal of Rheumatology The Journal of Rheumatology FM. (First Release Feb J Rheumatol · 2008
Inflammation in OsteoarthritisDieppe, P. · Rheumatology · 1978
Arthritogenic alphaviruses—an overviewSuhrbier, Andreas; Jaffar-Bandjee, Marie-Christine; Gasque, Philippe · Nature Reviews Rheumatology · 2012
Evaluation of 20Raees-Karami, Seyed Reza; Jafarieh, Hanieh; Ziyayi, Vahid; Shekarriz Foumani, Reza; Aghighi, Yahya · Clinical Rheumatology · 2012
Belimumab and the Clinical DataShum, Katrina; Askanase, Anca · Current Rheumatology Reports · 2012
Methylphenidate-associated myopathyVargas, Ana; Bica, Blanca ERG · Pediatric Rheumatology · 2012
Treatment of scleromyxedema with IVIgMoser, David W; Griffin, Thomas A · Pediatric Rheumatology · 2012
Bone remodelling in osteoarthritisBurr, David B.; Gallant, Maxime A. · Nature Reviews Rheumatology · 2012